Skip to main content
. 2021 Apr 3;152:112160. doi: 10.1016/j.fct.2021.112160

Fig. 10.

Fig. 10

Molecular docking study against SARS-CoV-2 major druggable target, MPro, where A and B represents the 3D and 2D docked pose for Rutin; C and D represent the 3D, and 2D docked pose for narcissin and; E and F represent the 3D, and 2D docked pose for Luteolin 7-galactoside.